Lecture

Sustained Proliferation: RTK/PI3K/mTOR Pathway in Cancer

Description

This lecture delves into the mechanisms of sustained proliferation in cancer, focusing on the RTK/PI3K/mTOR pathway and its inhibitors like Trastuzumab, Lapatinib, and Gefitinib. It explores the activation of PI3K by p-RTK and Ras, the completed randomized trials of PI3K and AKT inhibitors in breast cancer, and the effects of Akt/PKB on survival, proliferation, and cell growth. The lecture also covers the canonical Wnt/ß-catenin signaling pathway, Familial Adenomatous Polyposis (FAP), and the role of GPCRs and G-proteins in human cancers. It concludes by discussing the progression of colorectal cancer and the additional hallmark capabilities required for its development.

About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.